Amit Choudhary

USPTO Granted Patents = 11 (Patent Applications = 19)

EPO Patents = 1 (Patent Applications = 9)

Average Co-Inventor Count = 4.1

ph-index = 1

Location History:

Cambridge, MA (US) (2023)
Boston, MA (US) (2023 - 2024)

Company Filing History:

9 out of 443

The Broad Institute, Inc.

patents

9 out of 1,370

The Brigham and Women's Hospital, Inc.

patents

2 out of 15,458

University of California

Massachusetts Institute of Technology

patents

where one patent can have more than one assignee

Years Active: 2023-2025

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12473537 - Three-dimensional cell culture, devices, and use thereof (2025-11-18),

2. 12460244 - Inhibitors of RNA-guided nuclease activity and uses thereof (2025-11-04),

3. 12435320 - CRISPR having or associated with destabilization domains (2025-10-07),

4. 12421507 - Methods and compositions for optochemical control of CRISPR-CAS9 (2025-09-23),

5. 12404348 - Bifunctional chimeric molecules for labeling of kinases with target binding moieties and methods of use thereof (2025-09-02),

6. 12391685 - Inhibitors of RNA-guided nuclease target binding and uses thereof (2025-08-19),

7. 12227742 - Nucleic acid modifiers (2025-02-18),

8. 12208140 - Targeted delivery to beta cells (2025-01-28),

9. 11965159 - Compositions and methods for regulating proteins and nucleic acids activities (2024-04-23),

10. 11787795 - Inhibitors of RNA guided nucleases and uses thereof (2023-10-17),

11. 11760984 - CRISPR protein inhibitors (2023-09-19),

Title: Innovations and Contributions of Inventor Amit Choudhary

Introduction

Amit Choudhary is a prominent inventor based in Boston, MA (US). He has made significant contributions to the field of biotechnology, particularly in the area of RNA-guided nucleases. With a total of 11 patents to his name, Choudhary's work has advanced our understanding and application of genetic engineering technologies.

Latest Patents

Choudhary's latest patents include groundbreaking innovations such as inhibitors of RNA-guided nuclease activity. These compositions and methods are designed to inhibit the function of RNA-guided endonucleases, providing valuable tools for researchers. Additionally, he has developed CRISPR systems associated with destabilization domains, which involve engineered CRISPR Cas9 and various delivery systems. These advancements have the potential to enhance the precision and efficacy of gene editing techniques.

Career Highlights

Throughout his career, Amit Choudhary has worked with esteemed organizations such as the Broad Institute, Inc. and Brigham and Women's Hospital, Inc. His experience in these institutions has allowed him to collaborate with leading scientists and contribute to cutting-edge research in the field of genetics.

Collaborations

Choudhary has collaborated with notable colleagues, including Basudeb Maji and Kurt Cox. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Amit Choudhary's contributions to biotechnology and genetic engineering are noteworthy. His patents and collaborations reflect a commitment to advancing scientific knowledge and improving gene editing technologies. His work continues to inspire future innovations in the field.

This text is generated by artificial intelligence and may not be accurate.